BLI Based Adenoma Surveillance Strategy

NCT04111601 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 217

Last updated 2022-11-30

No results posted yet for this study

Summary

Bowel cancer is the third most common cancer in the UK. It develops through smaller growths in the bowel called polyps. Early recognition and removal of these polyps result in prevention of developing bowel cancer in an individual. However, not all polyps will lead to cancer, certain polyps are just growths of normal tissue and can be left in the bowel. We therefore need to know which polyps to remove and which ones to leave. One way of doing this is to have a better look at these polyps. This can be done by new technologies. One of them is called Blue Light Imaging (BLI). This is a new light source at the end of the camera which is activated by the push of a button. It will help us in looking at these polyps more closely.

This helps us decide which polyps to remove and which ones are safe to leave as there is always a small risk in removing a polyp. It would also give us a better idea as to when to repeat the camera test if necessary (endoscopic surveillance). By reducing the number of polyps resected and sent to the pathology labs for diagnosis, the work load on the pathology department is also reduced and in the process, providing cost savings to the Trust, The study aims to see if using Blue Light during endoscopy helps us to identify and characterize small polyps better

Conditions

  • Colorectal Polyp

Interventions

DEVICE

Blue light imaging

Advanced virtual chromoendoscopy

Sponsors & Collaborators

  • King's College Hospital NHS Trust

    collaborator OTHER
  • Luzerner Kantonsspital

    collaborator OTHER
  • Catharina Ziekenhuis Eindhoven

    collaborator OTHER
  • University Medical Centre Ljubljana

    collaborator OTHER
  • Göteborg University

    collaborator OTHER
  • Humanitas Hospital, Italy

    collaborator OTHER
  • Nuovo Regina Margherita Hospital

    collaborator OTHER
  • MITERA Hospitals, Athens , Greece

    collaborator UNKNOWN
  • Portsmouth Hospitals NHS Trust

    lead OTHER_GOV

Principal Investigators

  • Pradeep Z Bhandari, Prof · Portsmouth Hospitals NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-16
Primary Completion
2022-10-15
Completion
2022-10-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04111601 on ClinicalTrials.gov